{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:29:25Z","timestamp":1786343365876,"version":"build-2736575974"},"reference-count":72,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"abstract":"<jats:p>Parkinson's disease is one of the fastest growing neurological disorders with regards to disability and death. Though this burden is felt globally, inequities in research, advocacy, prioritization and funding mean that the needs of people with Parkinson's disease in low- and middle-income countries, and from marginalized communities in high-income countries, remain poorly recognized. Parkinson's disease is increasingly being acknowledged as a global public health issue requiring a public health response. Global advocacy efforts, awareness-raising initiatives, research collaborations, partnerships and investment in Parkinson's disease have therefore accelerated in recent years, with the positioning of people affected by PD as authoritative voices paramount to this drive. Yet despite this progress, inequalities in access to treatments, care and support persist. Responding to the global burden posed by Parkinson's disease requires sustained, multi-sectoral, concerted action, building on an integrated and systems-oriented approach. The generation of momentum for a public health approach to Parkinson's disease must be met with implementation at the country level, alongside sufficient allocation of resources, monitoring and evaluation. The approach offered in this paper builds on the five cross-cutting strategic objectives outlined in the World Health Organization's Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031 (IGAP) implementation toolkit, offering a platform to build a unified global response to Parkinson's disease. Action should therefore center on the integrated themes of (1) prioritization and governance; (2) diagnosis, treatment and care; (3) promotion and prevention; (4) research and information systems; and (5) a tailored Parkinson's disease-specific public health approach.<\/jats:p>","DOI":"10.1177\/1877718x261448383","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:18:41Z","timestamp":1778167121000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["One world, one goal: Advocacy and policy for a unified Parkinson's response"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-6250","authenticated-orcid":false,"given":"Natasha","family":"Fothergill-Misbah","sequence":"first","affiliation":[{"name":"Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3"},{"key":"e_1_3_3_3_2","article-title":"Global burden of Parkinson's disease from 1990 to 2021: a population-based study","volume":"15","author":"Li M","year":"2025","unstructured":"Li M, Ye X, Huang Z, et al. Global burden of Parkinson's disease from 1990 to 2021: a population-based study. BMJ Open 2025; 15: e095610\u201320250427.","journal-title":"BMJ Open"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2026.100421"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04191-8"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00779-y"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70368"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200138"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3"},{"key":"e_1_3_3_11_2","volume-title":"Parkinson disease: a public health approach. Technical Brief","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Parkinson disease: a public health approach. Technical Brief. Geneva: World Health Organization, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240050983"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.1783"},{"key":"e_1_3_3_13_2","volume-title":"Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031. Geneva: World Health Organization, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240076624"},{"key":"e_1_3_3_14_2","volume-title":"Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031: implementation toolkit","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Intersectoral global action plan on epilepsy and other neurological disorders 2022\u20132031: implementation toolkit. Geneva: World Health Organization, 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240096356"},{"key":"e_1_3_3_15_2","volume-title":"Global status report on neurology","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Global status report on neurology. Geneva: World Health Organization, 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240116139"},{"key":"e_1_3_3_16_2","volume-title":"iSupport for Dementia","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. iSupport for Dementia. Geneva: World Health Organization, 2019. https:\/\/www.who.int\/publications\/i\/item\/9789241515863"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","unstructured":"Hand A Samarakoon D Greenwell K et al. Development and feasibility trial of iSupport-PD a digital intervention for carers of people with Parkinson\u2019s and cognitive impairment. ISRCTN 2025. 10.1186\/ISRCTN16483203","DOI":"10.1186\/ISRCTN16483203"},{"key":"e_1_3_3_18_2","volume-title":"Improving access to medicines for neurological disorders","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Improving access to medicines for neurological disorders. Geneva: World Health Organization, 2024. https:\/\/iris.who.int\/handle\/10665\/378216"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30180"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21236-8"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-026-01183-1"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00378-8"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13903"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29126"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30051"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28921"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2024.107619"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf296"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00891-7"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/1877718X251351990"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00946-9"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03414-0"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70231"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacsau.2c00300"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.03.002"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1155\/padi\/1319419"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01910-5"},{"key":"e_1_3_3_38_2","unstructured":"ASAP. Uncovering the roots of Parkinson's disease https:\/\/parkinsonsroadmap.org\/ (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_39_2","unstructured":"CRN. Sparking new discoveries for Parkinson's disease https:\/\/www.asapcrn.org\/ (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_40_2","unstructured":"PPMI. About PPMI https:\/\/www.ppmi-info.org\/about-ppmi (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_41_2","unstructured":"MJFF. ASAP initiative https:\/\/www.michaeljfox.org\/asap (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_42_2","unstructured":"U.S. Congress. H.R. 2365 Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson\u2019s Act https:\/\/www.congress.gov\/bill\/118th-congress\/house-bill\/2365 (2023)."},{"key":"e_1_3_3_43_2","unstructured":"Spark The Night. Top landmarks around the world to spark blue for Parkinson\u2019s awareness on April 11 https:\/\/www.worldparkinsonsnight.com\/2025-media-release (2025 accessed 03 March 2026)."},{"key":"e_1_3_3_44_2","unstructured":"World Parkinson Congress. 7th World Parkinson Congress https:\/\/wpc2026.org\/ (2026 accessed 06 March 2026)."},{"key":"e_1_3_3_45_2","volume-title":"WHO framework for meaningful engagement of people living with noncommunicable diseases, and mental health and neurological conditions","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. WHO framework for meaningful engagement of people living with noncommunicable diseases, and mental health and neurological conditions. Geneva: World Health Organization, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240073074"},{"key":"e_1_3_3_46_2","unstructured":"Parkinson's Europe. Parkinson's Europe: Who we are https:\/\/parkinsonseurope.org\/who-we-are\/ (2026 accessed 06 March 2026)."},{"key":"e_1_3_3_47_2","unstructured":"Parkinson's Africa. Parkinson's Africa: What we do https:\/\/www.parkinsonsafrica.org\/about-us\/what-we-do\/ (2026 accessed 06 March 2026)."},{"key":"e_1_3_3_48_2","unstructured":"MDS. About the Society https:\/\/www.movementdisorders.org\/MDS\/What-We-Do.htm (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_49_2","unstructured":"MDS. MDS Purpose Mission & Goals https:\/\/www.movementdisorders.org\/MDS\/About\/Who-We-Are\/Purpose-Mission\u2013Goals.htm (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01123-8"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27081"},{"key":"e_1_3_3_52_2","unstructured":"Parkinson's Foundation. Parkinson\u2019s Foundation Genetics Study to Launch in 10 Latin American Countries https:\/\/www.parkinson.org\/blog\/research\/pd-gene-latam-expansion (2025 accessed 03 March 2026)."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-213006"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28669"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70447"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/hex.70380"},{"key":"e_1_3_3_57_2","volume-title":"mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health Gap Action Programme (mhGAP) \u2013 version 2.0","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health Gap Action Programme (mhGAP) \u2013 version 2.0. Geneva: World Health Organization, 2016. https:\/\/www.who.int\/publications\/i\/item\/9789241549790"},{"key":"e_1_3_3_58_2","volume-title":"Atlas: country resources for neurological disorders - 2nd ed","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Atlas: country resources for neurological disorders - 2nd ed. Geneva: World Health Organization, 2017. https:\/\/www.who.int\/publications\/i\/item\/atlas-country-resources-for-neurological-disorders"},{"key":"e_1_3_3_59_2","unstructured":"MDS. Education https:\/\/www.movementdisorders.org\/MDS\/Education.htm (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_60_2","unstructured":"MJFF. The Edmond J. Safra Fellowship in movement disorders https:\/\/www.michaeljfox.org\/edmond-j-safra-fellowship-movement-disorders (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_61_2","unstructured":"Edmond J. Safra Philanthropic Foundation. Michael J. Fox Foundation for Parkinson's Research https:\/\/www.edmondjsafra.org\/2022\/07\/29\/michael-j-fox-foundation-for-parkinsons-research\/ (2026 accessed 14 April 2026)."},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.25.293460"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2025.105299"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/1877718X251344066"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230357"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00287-X"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230376"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30287-X"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00283-1"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29708"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/1877718X251378115"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3299"},{"key":"e_1_3_3_73_2","unstructured":"GP2. GP2 Visits Nigeria: Commissioning of Nigeria's First Molecular Laboratory for Parkinson's Disease Genetics https:\/\/gp2.org\/gp2-visits-nigeria-commissioning-of-nigerias-first-molecular-laboratory-for-parkinsons-disease-genetics\/ (2026 accessed 14 April 2026)."}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261448383","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261448383","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261448383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:57:26Z","timestamp":1786341446000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261448383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":72,"alternative-id":["10.1177\/1877718X261448383"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261448383","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1877718X261448383"}}